Head to Head Contrast: Prestige Consumer Healthcare (NYSE:PBH) vs. Jazz Pharmaceuticals (NASDAQ:JAZZ)

Jazz Pharmaceuticals (NASDAQ:JAZZ – Get Free Report) and Prestige Consumer Healthcare (NYSE:PBH – Get Free Report) are both healthcare companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, earnings, analyst recommendations, profitability, institutional ownership, valuation and risk.

Analyst Ratings

This is a breakdown of current recommendations for Jazz Pharmaceuticals and Prestige Consumer Healthcare, as reported by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Jazz Pharmaceuticals 0 2 17 1 2.95
Prestige Consumer Healthcare 1 3 1 0 2.00

Jazz Pharmaceuticals currently has a consensus target price of $294.25, indicating a potential upside of 21.44%. Prestige Consumer Healthcare has a consensus target price of $67.00, indicating a potential upside of 31.91%. Given Prestige Consumer Healthcare’s higher probable upside, analysts clearly believe Prestige Consumer Healthcare is more favorable than Jazz Pharmaceuticals.

Institutional & Insider Ownership

89.1% of Jazz Pharmaceuticals shares are held by institutional investors. Comparatively, 100.0% of Prestige Consumer Healthcare shares are held by institutional investors. 4.1% of Jazz Pharmaceuticals shares are held by company insiders. Comparatively, 1.5% of Prestige Consumer Healthcare shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Risk and Volatility

Jazz Pharmaceuticals has a beta of 0.38, indicating that its share price is 62% less volatile than the S&P 500. Comparatively, Prestige Consumer Healthcare has a beta of 0.3, indicating that its share price is 70% less volatile than the S&P 500.

Profitability

This table compares Jazz Pharmaceuticals and Prestige Consumer Healthcare’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Jazz Pharmaceuticals 4.37% 16.88% 6.46%
Prestige Consumer Healthcare 13.29% 11.28% 5.25%

Valuation & Earnings

This table compares Jazz Pharmaceuticals and Prestige Consumer Healthcare”s gross revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Jazz Pharmaceuticals $4.72 billion 3.30 -$356.15 million $2.94 82.41
Prestige Consumer Healthcare $1.09 billion 2.21 $190.30 million $3.24 15.68

Prestige Consumer Healthcare has lower revenue, but higher earnings than Jazz Pharmaceuticals. Prestige Consumer Healthcare is trading at a lower price-to-earnings ratio than Jazz Pharmaceuticals, indicating that it is currently the more affordable of the two stocks.

Summary

Jazz Pharmaceuticals beats Prestige Consumer Healthcare on 10 of the 15 factors compared between the two stocks.

About Jazz Pharmaceuticals

(Get Free Report)

Jazz Pharmaceuticals plc is a global biopharmaceutical company focused on developing and commercializing medicines for serious diseases, particularly in neuroscience and oncology. Founded in 2003, the company is headquartered in Dublin, Ireland, and serves patients in the United States and international markets. Its products include treatments for sleep disorders and seizure conditions, such as Xywav, Xyrem, Sunosi and Epidiolex. Jazz also offers medicines used in cancer care, including Zepzelca, Vyxeos and Rylaze, as well as Defitelio for a serious complication following stem cell transplantation.

About Prestige Consumer Healthcare

(Get Free Report)

Prestige Consumer Healthcare, Inc. develops, markets and distributes over-the-counter health and personal-care products. Its portfolio includes brands such as Dramamine for motion sickness, Clear Eyes for eye care, Chloraseptic for sore-throat relief, Compound W for wart removal, and Summer’s Eve for feminine care. The company’s products serve categories including eye and ear care, cough and cold relief, pain relief, digestive health, and women’s health. They are sold through retail channels such as drugstores, supermarkets, mass-market retailers and online sellers.

Receive News & Ratings for Jazz Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Jazz Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.